12:00 AM
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Deals

Dishman Pharmaceuticals & Chemical, Redx Pharma deal

Redx granted Dishman rights to IP covering its process technology to develop statins....

Read the full 42 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >